VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 10/1/2012 3:54:43 PM : Underperform Start Price: $18.29 VVUS Score: -11.66

the EU did not approve last week

Featured Broker Partners


Advertisement